stockrow
Saturday 7 November 2026
Export PGNY’s income statement to Excel — free account
Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
34.84
0.47
+1.37%
Follow PGNY
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
37.22 | 28.75 | 56.38 | 92.70 | 68.04 | 77.42 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 6 | 7 | 6 | 5 | 5 | 4 | — | — |
Altman Z-Score |
8.89 | 8.34 | 13.03 | 12.65 | 27.56 | 26.69 | 10.89 | — | — |
P/S ratio |
1.71 | 1.27 | 3.25 | 3.58 | 8.96 | 10.54 | 2.48 | 0.62 | 0.62 |
P/FCF ratio |
11.47 | 8.52 | 19.09 | 36.55 | 187.66 | 103.33 | 0.00 | 16.55 | 16.55 |
Altman Z″-Score (non-manufacturers) |
7.14 | 7.20 | 7.74 | 6.15 | 6.00 | 4.27 | 5.49 | (10.46) | (12.83) |
Beneish M-Score |
(3.45) | (3.33) | (3.23) | (2.38) | (1.22) | (1.33) | (1.70) | (2.53) | — |
P/Operating CF |
40.58 | 28.38 | 93.89 | 54.74 | 508.96 | 555.88 | (103.69) | 20.26 | 20.26 |
P/B ratio |
4.26 | 3.51 | 6.39 | 7.48 | 17.82 | 21.77 | 4.98 | 0.00 | 0.00 |
Price to Tangible BV |
4.49 | 3.65 | 6.53 | 7.73 | 18.75 | 23.62 | 5.69 | 0.00 | 0.00 |
EV/Sales |
1.47 | 1.08 | 2.91 | 3.35 | 8.73 | 10.23 | 2.15 | 0.60 | 0.60 |
EV/EBITDA |
20.99 | 17.80 | 49.16 | 105.67 | 129.96 | 344.18 | 41.79 | 11.60 | 11.60 |
EV/Operating CF |
9.01 | 7.02 | 16.79 | 32.78 | 167.91 | 97.49 | (321.74) | 14.43 | 14.43 |
EV/FCF |
9.88 | 7.24 | 17.12 | 34.16 | 182.86 | 100.36 | (109.92) | 16.15 | 16.15 |
Quick Ratio |
2.62 | 2.75 | 3.30 | 2.69 | 2.57 | 2.38 | 3.52 | 0.78 | 0.90 |
Current Ratio |
2.73 | 2.80 | 3.44 | 2.72 | 2.62 | 2.45 | 3.66 | 0.81 | 0.94 |
Net Debt/EBITDA |
(3.44) | (3.23) | (5.76) | (7.59) | (3.55) | (10.66) | (6.81) | (0.08) | (0.05) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.61% | 14.84% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.05) |
Asset Turnover |
1.91 | 1.71 | 1.68 | 1.75 | 1.64 | 1.71 | 2.40 | 2.76 | 1.27 |
Operating CF/Net income |
3.59 | 3.30 | 3.04 | 2.65 | 0.40 | 0.78 | 0.18 | 3.44 | 0.70 |
Capex/Depreciation |
(3.72) | (1.70) | (1.60) | (2.02) | (1.64) | (0.54) | (1.39) | (0.30) | (0.35) |
Interest Coverage |
— | — | — | 28.67 | 70.15 | 68.99 | 166.84 | (6.95) | (14.87) |
| 12.48% | 11.14% | 13.34% | 9.66% | 31.41% | 33.04% | (89.47%) | (0.69%) | 13.98% | |
| 8.67% | 7.97% | 9.55% | 6.74% | 21.49% | 22.98% | (8.94%) | 1.73% | (35.31%) | |
ROIC |
25.88% | 21.72% | 21.31% | 7.77% | 15.27% | 9.05% | 17.85% | 0.00% | 0.00% |
Return on Tangible Assets |
15.43% | 17.17% | 13.35% | 10.74% | 39.92% | 40.11% | (8.62%) | (13.52%) | 3,341.94% |
Average Days of Receivables |
62.39 | 73.59 | 81.10 | 111.35 | 98.10 | 80.08 | 74.78 | 80.77 | 85.44 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
17.01% | 15.93% | 16.22% | 18.30% | 15.94% | 17.89% | 15.60% | 21.71% | 37.88% |
Intangible Assets out of Total Assets |
0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.05 | 0.09 | 0.38 | 0.49 |
Share Based Compensation of Revenue |
10.23% | 10.98% | 11.26% | 12.80% | 6.73% | 3.72% | 2.20% | 2.84% | 3.21% |
Graham Net Nets |
0.15 | 0.19 | 0.12 | 0.10 | 0.03 | 0.03 | 0.17 | (0.93) | (0.93) |
Graham Number |
9.67 | 8.15 | 9.30 | 5.51 | 6.86 | 4.90 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
2.69% | 3.48% | 1.77% | 1.08% | 1.47% | 1.29% | (1.41%) | (3.26%) | (3.26%) |
Free Cash Flow Yield |
8.72% | 11.73% | 5.24% | 2.74% | 0.53% | 0.97% | (0.79%) | 6.04% | 6.04% |
Revenue per Share |
15.05 | 12.76 | 11.46 | 8.54 | 5.62 | 4.02 | 11.08 | 19.03 | 8.56 |
Operating CF per Share |
2.45 | 1.96 | 1.99 | 0.87 | 0.29 | 0.42 | (0.07) | 0.41 | (1.67) |
Capex per Share |
(0.21) | (0.06) | (0.04) | (0.04) | (0.02) | (0.01) | (0.14) | (0.10) | (0.11) |
Free Cash Flow per Share |
2.24 | 1.90 | 1.95 | 0.84 | 0.27 | 0.41 | (0.22) | 0.31 | (1.78) |
Cash per Share |
3.62 | 2.49 | 3.91 | 2.05 | 1.34 | 1.28 | 3.88 | 0.02 | 0.83 |
Shareholders Equity per Share |
6.02 | 4.61 | 5.82 | 4.09 | 2.83 | 1.95 | 5.51 | (17.17) | (17.19) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.02 | 4.61 | 5.82 | 4.09 | 2.83 | 1.95 | 5.51 | (17.17) | (17.19) |
Free Cash Flow |
191.78 | 173.70 | 185.17 | 77.15 | 23.91 | 35.17 | (4.49) | 1.69 | (10.09) |
Working Capital |
349.38 | 304.09 | 454.46 | 274.32 | 159.72 | 112.44 | 96.28 | (5.66) | (1.00) |
Capital Expenditures |
(18.41) | (5.40) | (3.64) | (3.24) | (2.13) | (1.04) | (2.96) | (0.58) | (0.61) |
Net Current Asset Value |
325.38 | 287.68 | 437.22 | 267.84 | 152.30 | 103.24 | 96.28 | (111.90) | (115.81) |
EV/EBIT |
22.21 | 18.63 | 50.97 | 112.92 | 135.18 | 422.77 | 51.00 | 14.62 | 14.62 |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
25.79 | 21.94 | 56.86 | 120.83 | 138.73 | 435.29 | 58.82 | 14.99 | 14.99 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.17 | 0.26 | 0.22 | 0.19 | 0.26 | 0.56 | 0.69 | 2.52 | 2.95 |
Cash ROIC |
23.21% | 26.72% | 20.03% | 13.62% | 6.44% | 12.73% | (2.31%) | (1.79%) | 11.49% |
Accounts Receivable Turnover |
5.66 | 4.89 | 4.52 | 4.20 | 4.76 | 5.62 | 6.53 | 6.08 | 2.80 |
Accounts Payable Turnover |
8.98 | 8.29 | 7.24 | 7.26 | 7.41 | 8.74 | 10.53 | 8.30 | 3.98 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
46.01 | 37.98 | 53.87 | 64.38 | 57.69 | 57.80 | 38.42 | 66.14 | 45.47 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
227.81 | 238.60 | 240.97 | 187.31 | 105.11 | 61.36 | 35.19 | 17.35 | 17.35 |
Average Payables |
109.58 | 110.26 | 117.36 | 85.34 | 52.46 | 31.45 | 17.48 | 10.35 | 10.35 |
Average Assets |
674.77 | 681.86 | 649.80 | 450.53 | 306.00 | 202.18 | 95.88 | 38.14 | 38.14 |
Average Common Equity |
469.05 | 487.75 | 465.20 | 314.40 | 209.38 | 140.61 | 9.58 | (96.37) | (96.37) |
Columns are period end dates · fundamentals updated 6 Nov 2026